In this section you will find the list of Clinical Practice Guidelines (CPGs) and other Clinical Decision Making Tools (CDMTs) compiled and classified on Quality Domains. Please go to Guidelines and other CDMTs Section to see the methodology followed.
*Please note that classification for CPGs and other CDMTs on Bleeding and Coagulation disorders and Lymphoid malignances on Quality Domains is ongoing. Documents will be searchable soon.
Subnetwork: Hemochromatosis and other iron disorders
Disease group/s:
Scope and Purpose: 5. Diagnosis and treatment
Patients' involvement?: Yes
Rigour of development: A - Evidence and consensus based
Subnetwork: Hemochromatosis and other iron disorders
Disease group/s:
Scope and Purpose: 5. Diagnosis and treatment
Patients' involvement?: No
Rigour of development: A - Evidence and consensus based
Link: https://www.ncbi.nlm.nih.gov/pubmed/21452290
Comment:
Some divergences with the European guidelines (namely on the value of the H63D variant).
Subnetwork: Hemochromatosis and other iron disorders
Disease group/s:
Scope and Purpose: 2. Diagnosis
Patients' involvement?: No
Rigour of development: A - Evidence and consensus based
Subnetwork: Hemochromatosis and other iron disorders
Disease group/s: Low iron availability for erythropoiesis, Rare defects in iron acquisition and transport:
Scope and Purpose: 5. Diagnosis and treatment
Patients' involvement?: Yes
Rigour of development: A - Evidence and consensus based
Subnetwork: Hemochromatosis and other iron disorders
Disease group/s:
Scope and Purpose: 3. Treatment
Patients' involvement?: Yes
Rigour of development: C - Expert opinion
Subnetwork: Hemochromatosis and other iron disorders
Disease group/s: non-HFE related hereditary hemochromatosis
Scope and Purpose: 2. Diagnosis
Patients' involvement?: No
Rigour of development: C - Expert opinion
